Improving Stroke Risk Assessment

We provide plaque analysis software for vessel wall imaging that enables clinicians to identify and characterize high-risk atherosclerotic plaque before it leads to strokes and other cardiovascular disease complications.

We are achieving our mission with innovative and validated products, an experienced team, application-focused design, quality execution, and academic, clinical, and business partnerships.  

 

VPDiagnostics has establisehd partnership with the Vascular Imaging Laboratory (VIL) at the University of Washington and other world-class research institutes. More than 15 years of pioneering research has led to numerous patented technologies for vessel wall MRI. VPDiagnostics has obtained exclusive licenses for these plaque analysis technologies. VPDiagnostics currently holds a 3 million dollar NIH grant to conduct clinical validation of these technologies.

 

VPDiagnostics offers FDA cleared software product: MRI-PlaqueView. Research on Stroke risk-profiling using MRI plaque imaging has been published on Stroke Journal. VPDiagnostics is conducting a multi-centers prospective clinical trial.